MVL5

Catalog Number	ACM464926032-1
CAS	464926-03-2
Structure
Description	N1-[2-((1S)-1-[(3-aminopropyl)amino]-4-[di(3-amino-propyl)amino]butylcarboxamido)ethyl]-3,4-di[oleyloxy]-benzamide New Multivalent Cationic Lipid for siRNA Delivery · Improved total gene silencing · Lower non-specific gene silencing · Lower toxicity
Synonyms	N1,N1,N4-tris(3-ammoniopropyl)-5-((2-(3,4-bis((Z)-octadec-9-en-1-yloxy)benzamido)ethyl)amino)-5-oxopentane-1,4-diaminium chloride
Molecular Weight	1164.862
Molecular Formula	C59H116Cl5N7O4
Purity	>99%
Exact Mass	1161.754
Form	Powder
Hygroscopic	No
Light Sensitive	No
Percent Composition	C 60.83%, H 10.04%, Cl 15.22%, N 8.42%, O 5.49%
Stability	1 Year
Storage Temperature	-20℃

Knowledge & Learning Case Study Q&A

Common Cationic Lipids and Their Applications in Vaccines

Messenger RNA (mRNA) vaccines have emerged as a groundbreaking tool in the realm of vaccine development. Unlike traditional vaccines, mRNA vaccines work by introducing genetic material encoding a specific antigen into cells, prompting the cells to produce the antigen themselves. This approach stimulates an immune response as the body identifies the antigen as foreign and generates antibodies to combat it. One of the key benefits of mRNA vaccines is their agility in design and production, allowing for rapid response to emerging threats such as viral outbreaks or mutations. Get more information on:

• Role of mRNA in Vaccine Development
• Importance of Cationic Lipids in mRNA Delivery
• Cationic Lipids in mRNA Vaccine Formulations
• Popular Cationic Lipids from Alfa Chemistry
• Examples of Cationic Lipids Utilized in Vaccines

Our products and services are for research use only and cannot be used for any clinical purposes.

Online Inquiry

MVL5 (464926-03-2)

Send A Message